Vancomycin-resistant enterococcal bacteremia:: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis

被引:0
|
作者
Chou, Yen-Yi [1 ]
Lin, Te-Yu [1 ]
Lin, Jung-Chung [1 ]
Wang, Ning-Chi [1 ]
Peng, Ming-Yieh [1 ]
Chang, Feng-Yee [1 ]
机构
[1] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Med, Div Infect Dis & Trop Med, Taipei 114, Taiwan
关键词
bacteremia; Enterococcus faecalis; Enterococcus faecium; vancomycin resistance;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background and Purpose: Vancomycin-resistant enterococci (VRE) have emerged as important nosocomial pathogens. This study was conducted to clarify the clinical features and outcome of patients with vancomycin-resistant enterococcal bacteremia. Methods: Patients with vancomycin-resistant enterococcal bacteremia treated at a medical center in northern Taiwan between November 1998 and July 2006 were reviewed. Clinical and bacteriological characteristics of Enterococcus faecium and Enterococcus faecalis were compared. Results: Twelve patients (6 males and 6 females) were included for analyses. The mean age was 69.3 years (range, 40 to 86 years), and 8 cases (66.7%) were older than 65 years. All patients had underlying disease. Two patients received total hip replacement before development of VRE bacteremia. Twelve patients had prior exposure to broad-spectrum antimicrobial therapy. Ten patients had prior intensive care unit stay and prior mechanical ventilation before VRE bacteremia. All of the patients (n = 12) had an intravascular catheter in place. Bacteremia was caused by E faecalis in 4 patients and by E faecium in eight. The portals of entry included urinary tract (8.3%), skin, soft tissue and bone (41.7%) and unknown sources (50.0%). E faecium showed a higher rate of resistance to ampicillin and teicoplanin than E faecalis (87.5% vs 0.0%, p=0.01). The 60-day mortality rate was higher in patients with E. faecium bacteremia than E faecalis bacteremia (62.5% vs 0.0%), although statistical significance was not obtained (p=0.08). Conclusions: VRE bacteremia may have an impact on the mortality and morbidity of hospitalized patients. Patients with bacteremia caused by vancomycin-resistant E faecium had a grave prognosis, especially immuno-suppressed patients. The prudent use of antibiotics and strict enforcement of infection control may prevent further emergence and spread of VRE.
引用
下载
收藏
页码:124 / 129
页数:6
相关论文
共 50 条
  • [31] Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium
    Huebner, J
    Wang, Y
    Krueger, WA
    Madoff, LC
    Martirosian, G
    Boisot, S
    Goldmann, DA
    Kasper, DL
    Tzianabos, AO
    Pier, GB
    INFECTION AND IMMUNITY, 1999, 67 (03) : 1213 - 1219
  • [32] New Combinations of Mutations in VanD-Type Vancomycin-Resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium Strains
    Depardieu, F.
    Foucault, M. -L.
    Bell, J.
    Dubouix, A.
    Guibert, M.
    Lavigne, J. -P.
    Levast, M.
    Courvalin, P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1952 - 1963
  • [33] A new chromogenic agar medium, chromID VRE®, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis
    Ledeboer, N.
    Tibbetts, R.
    Dunne, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S24 - S25
  • [34] A new chromogenic agar medium, chromID VRE, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis
    Ledeboer, Nathan A.
    Tibbetts, Robert J.
    Dunne, William A.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 59 (04) : 477 - 479
  • [35] Molecular characterization of clinical and environmental isolates of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from a teaching hospital in Wales
    Kuriyama, T
    Williams, DW
    Patel, M
    Lewis, MAO
    Jenkins, LE
    Hill, DW
    Hosein, IK
    JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 52 (09) : 821 - 827
  • [36] ENTEROCOCCUS-FAECIUM AND ENTEROCOCCUS-FAECALIS BACTEREMIA - ACQUISITION AND OUTCOME
    NOSKIN, GA
    PETERSON, LR
    WARREN, JR
    CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) : 296 - 301
  • [37] Vancomycin-Resistant Enterococcus faecium Bacteremia in a Tertiary Care Hospital: Epidemiology, Antimicrobial Susceptibility, and Outcome
    Rosa, Regis G.
    Schwarzbold, Alexandre V.
    dos Santos, Rodrigo P.
    Turra, Eduardo E.
    Machado, Denise P.
    Goldani, Luciano Z.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [38] Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia
    Chuang, Yu-Chung
    Lin, Hsin-Yi
    Chen, Pao-Yu
    Lin, Chi-Ying
    Wang, Jann-Tay
    Chen, Yee-Chun
    Chang, Shan-Chwen
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (08) : 1026 - 1034
  • [39] Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India
    Tripathi, A.
    Shukla, S. K.
    Singh, A.
    Prasad, K. N.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 34 (01) : 38 - 45
  • [40] The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections
    Ayobami, Olaniyi
    Willrich, Niklas
    Reuss, Annicka
    Eckmanns, Tim
    Markwart, Robby
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 1180 - 1193